Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T11213L |
Epertinib
S-22611 |
EGFR; HER | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Epertinib is a reversible and selective tyrosine kinase inhibitor of EGFR, HER2, and HER4 (IC50s: 1.48 nM, 7.15 nM, and 2.49 nM). It displays a strong antitumor activity. | |||
T11213 |
Epertinib hydrochloride
S-22611 hydrochloride |
EGFR; HER | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Epertinib hydrochloride (S-22611 hydrochloride) 是口服可逆的选择性EGFR、HER2和HER4抑制剂,IC50值分别为 1.48、7.15 和 2.49 nM,具有抗肿瘤活性。 |